Mechanics Bank Trust Department Eli Lilly & CO Transaction History

Mechanics Bank Trust Department

$719 Million
Q1 2025

A detailed history of Mechanics Bank Trust Department transactions in Eli Lilly & CO stock. As of the latest transaction made, Mechanics Bank Trust Department holds 5,385 shares of LLY stock, worth $3.91 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

5,385

Previous 5,465 1.46%

Holding current value

$3.91 Million

Previous $4.22 Million 5.43%

% of portfolio

0.62%

Previous 0.57%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 08, 2025	SELL	$725.72 - $929.72 $58,057 - $74,377	-80 Reduced 1.46%	5,385 $4.45 Million
Q4 2024 Jan 16, 2025	BUY	$727.2 - $932.06 $1.13 Million - $1.44 Million	1,549 Added 39.56%	5,465 $4.22 Million
Q3 2024 Oct 10, 2024	BUY	$772.14 - $960.02 $16,987 - $21,120	22 Added 0.56%	3,916 $3.47 Million
Q2 2024 Jul 12, 2024	SELL	$724.87 - $909.04 $177,593 - $222,714	-245 Reduced 5.92%	3,894 $3.53 Million
Q1 2024 Apr 12, 2024	SELL	$592.2 - $792.28 $336,369 - $450,015	-568 Reduced 12.07%	4,139 $3.22 Million
Q4 2023 Jan 10, 2024	SELL	$525.19 - $619.13 $72,476 - $85,439	-138 Reduced 2.85%	4,707 $2.74 Million
Q3 2023 Oct 10, 2023	SELL	$434.7 - $599.3 $199,962 - $275,678	-460 Reduced 8.67%	4,845 $2.6 Million
Q2 2023 Jul 10, 2023	BUY	$350.74 - $468.98 $131,176 - $175,398	374 Added 7.58%	5,305 $2.49 Million
Q1 2023 Apr 10, 2023	SELL	$310.63 - $364.82 $76,725 - $90,110	-247 Reduced 4.77%	4,931 $1.69 Million
Q4 2022 Jan 23, 2023	SELL	$321.55 - $374.67 $65,596 - $76,432	-204 Reduced 3.79%	5,178 $0
Q3 2022 Oct 18, 2022	SELL	$296.48 - $337.87 $45,657 - $52,031	-154 Reduced 2.78%	5,382 $1.74 Million
Q2 2022 Jul 13, 2022	SELL	$278.73 - $327.27 $231,345 - $271,634	-830 Reduced 13.04%	5,536 $1.8 Million
Q1 2022 May 02, 2022	SELL	$234.69 - $291.66 $38,019 - $47,248	-162 Reduced 2.48%	6,366 $1.82 Million
Q4 2021 Jan 26, 2022	SELL	$224.85 - $279.04 $12,366 - $15,347	-55 Reduced 0.84%	6,528 $1.8 Million
Q3 2021 Oct 28, 2021	SELL	$221.6 - $272.71 $35,234 - $43,360	-159 Reduced 2.36%	6,583 $1.52 Million
Q2 2021 Jul 29, 2021	SELL	$180.55 - $233.54 $17,693 - $22,886	-98 Reduced 1.43%	6,742 $1.55 Million
Q1 2021 Apr 30, 2021	SELL	$164.32 - $212.72 $20,704 - $26,802	-126 Reduced 1.81%	6,840 $1.28 Million
Q4 2020 Feb 02, 2021	SELL	$130.46 - $172.63 $1.64 Million - $2.17 Million	-12,552 Reduced 64.31%	6,966 $1.18 Million
Q4 2020 Jan 27, 2021	BUY	$130.46 - $172.63 $1.64 Million - $2.16 Million	12,539 Added 179.67%	19,518 $1.18 Million
Q3 2020 Nov 05, 2020	BUY	$146.22 - $169.13 $382,657 - $442,613	2,617 Added 60.0%	6,979 $1.03 Million
Q2 2020 Jul 24, 2020	SELL	$136.42 - $164.18 $34,105 - $41,045	-250 Reduced 5.42%	4,362 $716,000
Q3 2019 Oct 18, 2019	SELL	$106.79 - $116.16 $20,824 - $22,651	-195 Reduced 4.06%	4,612 $516,000
Q1 2019 Apr 24, 2019	SELL	$111.31 - $131.02 $22,262 - $26,204	-200 Reduced 3.99%	4,807 $624,000
Q4 2017 Jan 29, 2018	SELL	$81.94 - $87.89 $40,970 - $43,945	-500 Reduced 9.08%	5,007 $423,000
Q3 2017 Oct 27, 2017	BUY	$77.07 - $85.54 $424,424 - $471,068	5,507	5,507 $471,000

Others Institutions Holding LLY

# of Institutions

4,384

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $689B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mechanics Bank Trust Department, based on Form 13F filings with the SEC.

News

Stay updated on Mechanics Bank Trust Department with notifications on news.

Account

Mechanics Bank Trust Department Eli Lilly & CO Transaction History